“IC50: An Unsuitable Measure for Large-Sized Prostate Cancer Spheroids in Drug Sensitivity Evaluation”. 2022. Biomolecules and Biomedicine 22 (4): 580-92. https://doi.org/10.17305/bjbms.2022.7279.